Study summary

To compare how well the new formulation of Tacrolimus® used once daily, in combination with other drugs helps prevent the rejection of a new kidney after transplantation compared to the twice daily dose of Tacrolimus

Additional Study Details

Phase
4
Product
N/A
Product
Prograf®
Advagraf®
Mycophenolate Mofetil
Simulect
methylprednisolone / prednisone
Type
Interventional
Masking
None (Open Label)
Enrollment number
1252
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A study in kidney transplant subjects to investigate the optimal suppression of immunity to help prevent kidney rejection? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Completed
    Alicante, Spain, 03010
    Completed
    Oviedo, Spain, 33006
    Completed
    Rennes Cedex 9, France, 35033
    Completed
    Banska Bysterica, Slovakia, 975 17
    Completed
    Madrid, Spain, 28007
    Completed
    Szeged, Hungary, 6720
    Completed
    Lyon Cedex 3, France, 69437
    Completed
    Dublin, Ireland
    Withdrawn
    Roma, Italy, 00168
    Completed
    Bucharest, Romania, 022328
    Completed
    Brussels, Belgium, 1070
    Completed
    Salamanca, Spain, 37007
    Completed
    Wien, Austria, A-1090
    Completed
    Bialystok, Poland, 15-540
    Completed
    Palma de Mallorca, Spain, 07014
    Completed
    Budapest, Hungary, 1082
    Completed
    Barcelona, Spain, 08907
    Completed
    Moscow, Russian Federation, 123182
    Completed
    Barakaldo-Vizcaya, Spain, 48903
    Completed
    Padova, Italy, 35128
    Completed
    Vandoeuvre, France, 54511
    Terminated
    Cadiz, Spain, 11009
    Completed
    Jena, Germany, 07747
    Completed
    La Tronche, France, 38700
    Completed
    Toulouse Cedex, France, 31054
    Completed
    Zurich, Switzerland, 8091
    Withdrawn
    Moscow, Russian Federation, 119992
    Withdrawn
    Coimbra, Portugal, 3000-075
    Completed
    Zaragoza, Spain, 50009
    Completed
    Frankfurt, Germany, 60590
    Completed
    Cluj Napoca, Romania, 400006
    Completed
    Paris Cedex 15, France, 75743
    Completed
    Lisboa, Portugal, 1069-639
    Completed
    Maastricht, Netherlands, 6202 AZ
    Completed
    Berlin, Germany, 13353
    Completed
    Moscow, Russian Federation, 129090
    Completed
    Valencia, Spain, 46009
    Completed
    Warsaw, Poland, 022-006
    Completed
    Madrid, Spain, 28046
    Completed
    Roma, Italy, 00144
    Withdrawn
    Bochum, Germany, 44892
    Completed
    Freiburg i. Br, Germany, 79106
    Completed
    Innsbruck, Austria, A-6020
    Completed
    Paris Cedex 20, France, 75970
    Completed
    Limoges Cedex 1, France, 87042
    Completed
    Prague, Czech Republic, 14021
    Completed
    Murcia, Spain, 30120
    Completed
    Rostock, Germany, 18057
    Completed
    Madrid, Spain, 28034
    Completed
    Stockholm, Sweden, S-14186
    Completed
    Treviso, Italy, 31100
    Completed
    Strasbourg Cedex, France, 67091
    Completed
    Paris Cedex, France, 75908
    Completed
    Ostrava, Czech Republic, 70852
    Completed
    Brest Cedex 2, France, 29609
    Completed
    Athens, Greece, 11527
    Completed
    Uppsala, Sweden, S-75185
    Completed
    Volgograd, Russian Federation, 404120
    Completed
    Tubingen, Germany, 72076
    Completed
    Wroclaw, Poland, 50-419
    Completed
    Milano, Italy, 20162
    Completed
    Manchester, United Kingdom, M13 9WL
    Completed
    Hradec Kravlove, Czech Republic, 50005
    Withdrawn
    Nicosia, Greece, 1102
    Completed
    Hannover, Germany, 30625
    Completed
    Lublin, Poland, 20-090
    Completed
    Le Kremlin Bicetre Cedex, France, 94275
    Completed
    Suresnes Cedex, France, 92151
    Completed
    Glasgow, United Kingdom, G11 6NT
    Completed
    Buenos Aires, Argentina, C1425FAB
    Completed
    Munster, Germany, 48149
    Completed
    Leuven, Belgium, 3000
    Completed
    Kiel, Germany, 24105
    Completed
    St. Petersburg, Russian Federation, 197110
    Completed
    Cape Town, South Africa, 7925
    Withdrawn
    Milano, Italy, 20122
    Completed
    Barcelona, Spain, 08035
    Terminated
    Granada, Spain, 18012
    Completed
    Omsk, Russian Federation, 644112
    Completed
    Porto, Portugal, 4099-001
    Completed
    Siena, Italy, 53100
    Completed
    Sevilla, Spain, 41013
    Completed
    Munchen, Germany, 81675
    Completed
    Nantes, France, 44035
    Completed
    Cordoba, Argentina, X5016KEH
    Completed
    A Coruna, Spain, 15006
    Completed
    Angers Cedex 01, France, 49033
    Completed
    Regensburg, Germany, 93042
    Completed
    Leicester, United Kingdom, LE54PW
    Completed
    Ancona, Italy, 60020
    Completed
    Tours Cedex 9, France, 37044
    Completed
    Brno, Czech Republic, 65691
    Completed
    Johannesburg, South Africa, 2193
    Completed
    Bologna, Italy, 40138
    Completed
    Thessaloniki, Greece, 54642
    Completed
    Birmingham, United Kingdom, B15 2TH
    Completed
    Linz, Austria, A-4010
    Completed
    Pamplona, Spain, 31080
    Completed
    Halle, Germany, 06120
    Completed
    Oslo, Norway, NO-0027
    Withdrawn
    Liverpool, United Kingdom, L7 8XP
    Completed
    Ghent, Belgium, 9000
    Completed
    Albacete, Spain, 02006
    Completed
    Creteil Cedex, France, 94010
    Completed
    Essen, Germany, 45147
    Completed
    Nice Cedex, France, 06002
    Completed
    St. Etienne, France, 42055
    Completed
    Valencia, Spain, 46017
    Withdrawn
    Kobenhavn, Denmark, DK-2100
    Completed
    Poznan, Poland, 60-479
    Completed
    Hamburg, Germany, 20251
    Completed
    Leipzig, Germany, 04103
    Withdrawn
    Porto, Portugal, 4200-319
    Completed
    Kaiserslautern, Germany, 67655
    Completed
    Brussels, Belgium, 1200
    Completed
    Kosice, Slovakia, 040 11
    Completed
    Gdansk, Poland, 80-211
    Completed
    Bordeaux, France, 33076
    Completed
    Aachen, Germany, 52074

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?